Trial Profile

Comparison of Humoral Response to Conjugate Pneumococcal Vaccine and Polysaccharide Pneumococcal Vaccine in Rheumatoid Arthritis (RA) Patients Treated With Abatacept

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Jan 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary) ; Abatacept
Indications Pneumococcal infections
Focus Pharmacodynamics
Acronyms VACINA

Most Recent Events

15 Nov 2023 Results assessing humoral response 1, 6 and 12 months after vaccination with PCV13/PPSV23 or PPSV23 in RA patients starting abatacept presented at the ACR Convergence 2023
01 Mar 2021 Status changed from active, no longer recruiting to completed.
27 Jan 2020 Planned End Date changed from 1 Mar 2020 to 1 Jan 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com